Prevalence and characteristics of covert contraceptive use in the Performance Monitoring for Action multi-country study.

Covert contraceptive use Family planning Partner dynamics sub-Saharan Africa

Journal

Contraception: X
ISSN: 2590-1516
Titre abrégé: Contracept X
Pays: United States
ID NLM: 101767748

Informations de publication

Date de publication:
2022
Historique:
received: 30 07 2021
revised: 12 04 2022
accepted: 13 04 2022
entrez: 27 5 2022
pubmed: 28 5 2022
medline: 28 5 2022
Statut: epublish

Résumé

A more nuanced understanding of contributors to covert contraceptive use remains critical to protecting covert users and reducing its necessity. This study aimed to examine the overall prevalence of covert use, and sociodemographic characteristics associated with covert vs overt use across multiple geographies in sub-Saharan Africa and Asia. Performance Monitoring for Action (PMA) is one of the few nationally representative surveys that measures covert use across socially diverse contexts via a direct question. Utilizing PMA 2019-2020 phase 1 data from Burkina Faso, Côte D'Ivoire, Kenya, Democratic Republic of Congo (DRC; Kinshasa and Kongo Central regions), Uganda, Nigeria (Kano and Lagos), Niger, and Rajasthan, we estimated overall prevalence of covert use. We conducted bivariate analyses and multivariate logistic regressions for 6 sites, comparing the odds of covert use with overt use among users of contraception by sociodemographic characteristics. Covert use ranged from 1% in Rajasthan to 16% in Burkina Faso. Marital status was the only sociodemographic characteristic consistently associated with type of use across sites. Specifically, polygynous marriage (compared to monogamous) increased odds of using covertly, ranging from adjusted odds ratio (aOR) of 1.8 [95% confidence interval (CI) 1.2-2.7] in Burkina Faso to 6.2 [95% CI 2.9-13.3] in Kinshasa. Unmarried women with partners or boyfriends were also more likely to be using covertly compared with their monogamously married counterparts in all sites (aORs ranged from 2.2 [95% CI 1.0-4.7] in Uganda to 4.4 [95% CI 1.7-11.0] in Kinshasa). Understanding factors associated with covert use has programmatic and policy implications for women's reproductive autonomy. Covert use is a common phenomenon across most sites, representing a small but programmatically important contingent of users. Family planning providers and programs must protect access to and maintain privacy of reproductive services to this population, but should also focus on creating interventions and environments that support overt use.

Identifiants

pubmed: 35620730
doi: 10.1016/j.conx.2022.100077
pii: S2590-1516(22)00006-5
pmc: PMC9127266
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100077

Informations de copyright

© 2022 The Author(s). Published by Elsevier Inc.

Références

Soc Sci Med. 2009 Nov;69(10):1547-55
pubmed: 19765879
PLoS One. 2021 Nov 29;16(11):e0257009
pubmed: 34843466
Cult Health Sex. 2019 Dec;21(12):1439-1451
pubmed: 30762484
BMC Public Health. 2020 Jun 5;20(1):865
pubmed: 32503485
Stud Fam Plann. 2018 Jun;49(2):143-157
pubmed: 29845621
BMC Womens Health. 2019 Jul 22;19(1):99
pubmed: 31331306
Reprod Health. 2019 Feb 11;16(1):17
pubmed: 30744697
Contraception. 2018 Jul;98(1):41-46
pubmed: 29514043
Stud Fam Plann. 1998 Dec;29(4):360-72
pubmed: 9919630
PLoS One. 2020 Nov 18;15(11):e0242345
pubmed: 33206705
Reprod Health. 2020 Apr 20;17(1):57
pubmed: 32312279
Stud Fam Plann. 1999 Sep;30(3):231-48
pubmed: 10546314
BMJ Glob Health. 2018 Dec 30;3(6):e000975
pubmed: 30687521
BMC Womens Health. 2016 Jun 06;16:31
pubmed: 27266263
PLoS One. 2021 Jan 12;16(1):e0238662
pubmed: 33434205
BMC Public Health. 2021 Jul 5;21(1):1316
pubmed: 34225673
J Biosoc Sci. 2018 May;50(3):326-346
pubmed: 28720152
Stud Fam Plann. 2017 Sep;48(3):293-303
pubmed: 28885679

Auteurs

Dana O Sarnak (DO)

Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Elizabeth Gummerson (E)

Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Shannon N Wood (SN)

Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Funmilola M OlaOlorun (FM)

Department of Community Medicine, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.

Simon Peter Sebina Kibira (SPS)

Department of Community Health and Behavioral Sciences, School of Public Health, Makerere University, Kampala, Uganda.

Linnea A Zimmerman (LA)

Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Philip Anglewicz (P)

Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Classifications MeSH